MADRIGAL PHARMACEUTICALS, INC. (MDGL) › Shareholders' EquityMADRIGAL PHARMACEUTICALS, INC. (MDGL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: -$58.79M2009: $24.91M2010: $23.48M2011: $14.77M2012: $75.07M2013: $49.09M2014: -$42.07M2015: -$48.91M2016: $36.41M2017: $182.26M2018: $476.98M2019: $416.56M2020: $239.97M2021: $196.11M2022: $197.39M2023: $405.33M2024: $754.38M2025: $602.69M$602.69M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$602.69M-20.1%2024$754.38M+86.1%2023$405.33M+105.3%2022$197.39M+0.7%2021$196.11M-18.3%2020$239.97M-42.4%2019$416.56M-12.7%2018$476.98M+161.7%2017$182.26M+400.6%2016$36.41M+174.4%2015-$48.91M-16.3%2014-$42.07M-185.7%2013$49.09M-34.6%2012$75.07M+408.1%2011$14.77M-37.1%2010$23.48M-5.7%2009$24.91M+142.4%2008-$58.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share